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utophagy (literally, self-eating) 
was fi  rst described in the 1950s, 
but the last decade has seen an 
explosion of interest in this degradative 
pathway. Cytoplasmic components are 
enclosed in a double-membraned vesi-
cle—the autophagosome—and delivered 
to the lysosome to be broken down.
Daniel Klionsky didn’t set out to study 
this process. In fact he was initially disap-
pointed when, as a junior faculty member at 
UC Davis, he discovered that the unusual 
protein-targeting pathway he worked on in 
yeast was actually a specialized version of 
autophagy (1). The cytoplasm to vacuole 
targeting (Cvt) pathway delivers the en-
zyme aminopeptidase I directly to the 
yeast equivalent of lysosomes (2), diverging 
from the usual transport of vacuole en-
zymes through the secretory pathway that 
Klionsky studied as a postdoc with Scott 
Emr at Caltech (3). Before that, Klionsky, 
a California native, was a biology major 
at UCLA and a graduate stu-
dent at Stanford, investigating 
the bacterial ATP synthase 
with Bob Simoni (4).
Klionsky eventually left 
his home state in 2000, mov-
ing to the University of 
Michigan’s Life Sciences 
Institute where he has con-
tinued to study autophagy in 
yeast, recently uncovering 
proteins that target damaged 
mitochondria for degradation (5). In ad-
dition, Klionsky has developed new ap-
proaches to teaching science (6) that 
have earned him educational grants 
from the NSF and the Howard Hughes 
Medical Institute. Also the editor of the 
journal Autophagy, Klionsky was nev-
ertheless happy to make time in his busy 
schedule to discuss his research and extra-
curricular activities.
SETTING SAIL
Did you always want to be a scientist?
I actually started college as a history major. 
But I wondered what I’d do with that after 
I graduated, so I switched to science—
I’d enjoyed biology in high school. My 
main interest was marine biology, and I 
even had an offer to go to grad school at the 
Scripps Institute of Oceanography. But my 
professors at UCLA told me to focus on 
basic science for my PhD. I should’ve 
known that marine biology wasn’t the sub-
ject for me, because I’m prone to getting 
seasick. I spent an academic quarter at the 
research station on Santa Catalina Island, 
and we took these huge, slow boats out 
there. I was so ill by the time I got to the 
island that I remember seriously thinking, 
“What am I going to do here for the rest 
of my life? Because there’s no way I’m 
getting on that boat again to go back.”
Of all the basic science you could’ve 
done in grad school, how did you end up 
working on the bacterial ATP synthase?
One of my courses at UCLA was taught 
by an electron microscopist who had done 
some of the early work on the mitochon-
drial ATP synthase. He was a 
good instructor, and I found 
the subject interesting. I inter-
viewed at Stanford, and 
talked with Bob Simoni, and 
it just clicked in my mind: 
“That enzyme really is fasci-
nating. This could be great.” 
And I also felt—correctly—
that Bob would be a wonder-
ful person to work with.
Why did you change ﬁ  elds and work 
with Scott Emr for your postdoc?
During graduate school, I developed an 
interest in protein targeting. Bacteria aren’t 
a great system for that so I decided to 
switch to a eukaryote. I wasn’t keen on 
working in mammalian cells—half of 
Bob’s lab worked on mammalian tissue 
culture and I saw how I could start a bacte-
rial culture at night to do an experiment the 
next day, whereas the people doing tissue 
culture would have to plan weeks ahead.
I went to interview with Scott and it 
was another really good connection. He 
was almost jumping out of his seat with 
excitement, telling me about his research. 
I felt that if I was ever run down by my 
project, I could just plug into this guy and 
he’d re-energize me. He worked on pro-
tein targeting in a fairly simple system—
I didn’t know much about yeast but I 
knew it was relatively easy to work with—
and to top it all off, I could stay in Cali-
fornia. It was a match made in heaven.
A JUNK PATHWAY
How did you end up on autophagy?
I mapped the vacuolar targeting signal in 
proteinase A in Scott’s lab, and I suggested 
that I could do the same for aminopepti-
dase I (ApeI). Scott essentially said, “Who 
cares? It’s another vacuolar hydrolase and 
it won’t be that much more interesting.”
When I started my own lab, Scott for-
warded me a letter from someone looking 
for a postdoc and said, “I can’t take this per-
son, but I thought you might be interested.” 
The postdoc was from one of the labs that 
had sequenced the APEI gene and I sug-
gested that we take a look at the correspond-
ing enzyme. That led us to the Cvt pathway, 
because we discovered it didn’t traffi  c 
through the regular secretory pathway. I 
owe my career to Scott’s lack of interest!
We got some Cvt pathway mutants 
and, because nothing had been cloned, to 
see if they were unique I compared them 
with other mutants that had been isolated. 
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Even though they were completely uncon-
nected in my mind, I got autophagy mutants 
from Yoshinori Ohsumi’s and Michael 
Thumm’s labs. I was shocked and depressed 
to fi  nd almost a complete overlap. At that 
time, autophagy was thought of as a garbage 
disposal system. Who’d want to study that?
What changed your mind?
We started to collaborate with the Ohsumi 
lab and sent them some antisera to ApeI. 
I got a phone call from Yoshinori saying, 
“You must come and look at these results. 
It’s very interesting—I can’t explain it to 
you.” I said, “Are you sure you can’t give me 
a hint? You’re in Japan, I can’t just hop over 
there!” But he arranged for me to visit and he 
showed me these EM images from Misuzu 
Baba where clusters of ApeI were inside 
double-membraned vesicles. They weren’t 
being taken up as if they were junk, it was 
clearly a more specialized mechanism.
Suddenly it was a lot more exciting. It 
wasn’t just a garbage pathway. Then, in 
1999, Beth Levine’s lab made the fi  rst 
connection between autophagy and dis-
ease, showing that it suppresses tumors. 
For me, that was the last little bit in terms 
of making it exciting, and almost yearly 
after that, the pathway has been linked 
to other diseases—neurodegeneration, 
removal of pathogens, aging—one thing 
after another. The fi   eld, particularly in 
higher eukaryotes, has exploded.
What are some of the big questions in the 
autophagy ﬁ  eld at the moment?
We still have fundamental questions about 
how the autophagy machinery works. There 
are presently 33 autophagy-related genes in 
yeast and we know the absolute function of 
perhaps half a dozen. How does autophagy 
target different things, like damaged or-
ganelles? We recently screened for mutants 
defective in selective mitochondrial degra-
dation and identifi  ed several new genes.
Where does the membrane that forms the 
autophagosome come from? And how is it 
commandeered for the pathway when au-
tophagy is up-regulated? We’re doing a lot of 
work on the pathway’s regulation right now: 
we have an exciting project on a transcrip-
tion factor that controls an important step.
The role of autophagy in various diseases 
isn’t very clear. Autophagy occurs in some 
myopathies, but it’s not known whether it’s 
protective or the cause of the disease. And 
how autophagy acts in tumor suppression is 
largely unknown. The pathway can cause 
both cell survival and cell death, so we have 
to understand its regulation better if we’re 
going to exploit it for therapeutic purposes.
EXTRACURRICULAR ACTIVITIES
You’re the founding editor of the journal 
Autophagy. How did that come about?
When Landes Bioscience asked me to start 
this journal, my initial response was, “It’s 
not the right time, the fi  eld’s too young.” But 
the publisher, Ron Landes, replied, “If you 
wait until it’s time, it’ll be too late,” meaning 
that someone else will have started it and I 
wouldn’t get to be in charge. So I thought 
why not give it a try? I didn’t know what I 
was getting into though. Producing the fi  rst 
issue isn’t a big deal because you can publish 
whenever you’re ready to go. But you have a 
deadline for the second issue, so you’re 
pleading for articles to come in.
Also, I foolishly envisioned all these pa-
pers coming in on yeast autophagy, but I’ve 
had to learn much more about autophagy in 
lots of other organisms too, which is great. 
The journal forces me to interact with lots of 
people. In 2008, we published a paper that 
set guidelines for monitoring autophagy in 
higher eukaryotes. It had over 200 authors 
and it was fun to write to all these people 
and say, “Hey, would you like to contribute 
to and endorse these guidelines?” I want to 
keep the autophagy community as friendly 
and interactive as possible. So, although the 
journal’s been more work than I expected, 
it’s also been very exciting.
You’re also interested in teaching, and 
take a different approach to your classes.
I view my teaching the same way I do my 
research: it’s an ongoing experiment to 
fi  nd what works best. I have pretty much 
eliminated lectures from my Introductory 
Biology course—it’s clear from many 
studies that lecturing isn’t an effective way 
for students to learn. It’s a method that 
originated before the invention of the print-
ing press as a way to give information ver-
bally, but we don’t need to do that now.
I give students my notes at the start of 
the term and require that they read them 
before class. I ensure they do it by giving 
them a reading quiz every session, which 
counts for half the course grade. With this 
approach I don’t have to lecture on that 
material and can spend the majority of the 
class solving problems instead. I’ll pose a 
problem, let them work on it in groups, and 
then we’ll discuss not only what the answer 
is, but the thought process that got them to 
that answer. It teaches students to work with 
facts rather than just memorize them.
Between research, teaching, and editing, 
do you have any hobbies outside of work?
I do, thanks to my wife, who keeps me 
from spending my entire life in the offi  ce. 
I’m currently taking a drawing class and 
teaching myself to play the guitar. In 
warmer months we like to garden. But 
yes, the academic life takes a huge amount 
of time; it can be all consuming. Really, 
you just have to know when it’s time to 
get on with the other parts of your life.
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Teaching is an important part of Klionsky’s work.
Klionsky holds a painting by David S. Goodsell 
that depicts the Cvt pathway.